Search Results - "Yalcinkaya, Isil"

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial by Chekerov, Radoslav, Hilpert, Felix, Mahner, Sven, El-Balat, Ahmed, Harter, Philipp, De Gregorio, Nikolaus, Fridrich, Claudius, Markmann, Susanne, Potenberg, Jochem, Lorenz, Ralf, Oskay-Oezcelik, Guelten, Schmidt, Marcus, Krabisch, Petra, Lueck, Hans-Joachim, Richter, Rolf, Braicu, Elena Ioana, du Bois, Andreas, Sehouli, Jalid, Lichtenegger, Werner, Yalcinkaya, Isil, Kittner, Marion, Konwert, Ellen, Keller, Maren, Mustea, Alexander, Koensgen-Mustea, Dominique, Pietzner, Klaus, Camara, Oumar, Wimberger, Pauline, Elser, Gabriele, Polleis, Sandra

“…Antiangiogenic therapy has known activity in ovarian cancer. The investigator-initiated randomised phase 2 TRIAS trial assessed the multi-kinase inhibitor…”
Get full text

Topotecan (T) + Pazopanib (P) in platinum-resistant or intermediate-sensitive ovarian cancer: a phase I/II single-arm multicentre trial of the North-Eastern German Society of Gynaecologic Oncology: TOPAZ by Chekerov, Radoslav, Canzler, Ulrich, Strauss, Hans-Georg, Müller, Volkmar, de Gregorio, Nikolaus, Hacker, Ulrich, Neunhoeffer, Tanja, Richter, Rolf, Braicu, Elena Ioana, Inci, Guelhan, Pietzner, Klaus, Yalcinkaya, Isil, Belau, Antje Kristina, von Abel, Ekkehard, Wimberger, Pauline, Sehouli, Jalid

“…Abstract only…”
Get full text

Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial by Braicu, Elena Ioana, Gasimli, Khayal, Richter, Rolf, Nassir, Mani, Kümmel, Sherko, Blohmer, Jens-Uwe, Yalcinkaya, Isil, Chekerov, Radoslav, Ignat, Iulia, Ionescu, Andra, Mentze, Monika, Fotopoulou, Christina, Pop, Carmen, Lichtenegger, Werner, Sehouli, Jalid

“…The aim of the current study was to analyze the type of variations in expression profiles of matrix metalloproteinase 2 (MMP2), matrix metalloproteinase 9…”
Get full text

Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial by Chekerov, Radoslav, Harter, Philipp, Fuxius, Stefan, Hanker, Lars Christian, Woelber, Linn, Müller, Lothar, Klare, Peter, Abenhardt, Wolfgang, Nedkova, Yoana, Yalcinkaya, Isil, Heinrich, Georg, Sommer, Harald, Mahner, Sven, Wimberger, Pauline, Koensgen-Mustea, Dominique, Richter, Rolf, Oskay-Oezcelik, Gülten, Sehouli, Jalid

“…Palliative systemic treatment in elderly gynaecological cancer patients remains a major challenge. In recurrent ovarian cancer (ROC), treosulfan an active…”
Get full text